[RGLS] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 26.75%
YoY- 18.91%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 5,000 18 18 18 204 1,865 1,083 29.00%
PBT -1,523 -5,423 -10,273 -15,835 -19,515 -13,016 -9,798 -26.65%
Tax 1 87 201 -7 4 -16 -2,259 -
NP -1,524 -5,423 -10,273 -15,828 -19,519 -13,000 -9,798 -26.64%
Tax Rate - - - - - - - -
Total Cost 6,524 5,441 10,291 15,846 19,723 14,865 10,881 -8.16%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -30.48 -30,127.78 -57,072.22 -87,933.33 -9,568.14 -697.05 -904.71 -43.13%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.40 -2.60 -11.80 -21.09 -44.33 -30.01 -27.09 -50.43%
EPS Diluted -0.40 -2.60 -11.80 -21.09 -44.33 -30.01 -26.21 -50.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.